The pandemic has drastically impacted cancer care, posing challenges in treatment and diagnosis. There is increasing evidence that cancer patients, particularly those who have significant comorbidities, metastatic disease, and/or are receiving active immunosuppressive therapy may be at higher risk of Covid-19 severe complications, writes Dr Amit Rauthan